SIRT6 and cancer: Within the tumor microenvironment, loss of SIRT6 in TSPAN8+ cancer-associated fibroblasts (CAFs) drives a senescence-like phenotype, metabolic reprogramming, and secretion of pro-tumorigenic metabolites that foster chemoresistance.